In order to get an extension on the Viagra patent, pharmaceutical company Pfizer is working on a deal with the Food & Drug Administration to sell a children’s form of the male enhancement-drug to treat a rare lung disorder that affects about 600 kids a year.
Here’s how it would work: Viagra modifies blood flow which could reduce unusually high blood pressure in a child’s lungs, also known as pulmonary arterial hypertension. Patients suffer chest pains, fatigue, and dizziness.
Viagra’s patent expires in 2012, but if Pfizer can create this children’s version of the drug to meet FDA requirements, the patent can be extended six months.
No Comments
